Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2013-07-31
2017-10-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
NCT06817148
Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
NCT03836521
Impact of Predilatation Between Self-expanding Valves
NCT04157920
Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
NCT02628899
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
NCT06212050
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Beta blocker therapy
Cohort will consist of those actively taking any beta blocker medication. Observation only.
No interventions
ARB therapy
Cohort will consist of those actively taking any angiotensin receptor blocker medication. Observation only.
No interventions
No therapy
Cohort will consist of those not taking either beta blocker nor angiotensin receptor blocker. Observation only.
No interventions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No interventions
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aortic measurement of 35 - 49 mm on prior imaging study
Exclusion Criteria
* Prior aortic dissection
* Other condition associated with enlarged aorta including Coarctation, Marfans, Turner syndrome, Loeys-Dietz, etc.
* Severe aortic stenosis or regurgitation
* Contraindication to MRI such as claustrophobia or implanted pacer/defibrillator
* Anticipated pregnancy, surgery, or move outside the area within 2 years
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Emory University
OTHER
University of Colorado, Denver
OTHER
Baylor College of Medicine
OTHER
University of California, Los Angeles
OTHER
Penn State University
OTHER
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Craig Broberg
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California
Los Angeles, California, United States
University of Colorado
Denver, Colorado, United States
Emory University
Atlanta, Georgia, United States
Oregon Health and Science University
Portland, Oregon, United States
Penn State
Hershey, Pennsylvania, United States
Baylor College of Medicine
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OHSU IRB 8330
Identifier Type: -
Identifier Source: secondary_id
1R34HL115032-01A1--BAV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.